1400067410334470145

#ICYMI Alana Hippensteele of @Pharmacy_Times interviewed Dr. Mitchell Horwitz, principal investigator and professor of medicine at the @DukeCancer Institute, on the results of a Phase 3 study of omidubicel. Read more at: https://t.co/mDQ6fqRtqF

Send us a message